Joseph H. Wender is Director at IONIS PHARMACEUTICALS INC (IONS). They have made 13 open-market trades across 3 companies since 2007, most recently 2025-12-01.
CIK 0001073384
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IONS | SELL · 10b5-1 | 2025-12-01 | 2025-12-03 | $80.82 | $4.5M | -2.6% | -2.7% | -4.0% |
| IONS | SELL · 10b5-1 | 2025-10-30 | 2025-11-03 | $73.74 | $3.3M | -3.5% | +13.0% | +14.7% |
| IONS | SELL · 10b5-1 | 2025-10-01 | 2025-10-02 | $65.50 | $1.1M | +4.4% | +7.8% | +15.8% |
| IONS | SELL · 10b5-1 | 2025-09-02 | 2025-09-04 | $57.58 | $1.6M | +3.2% | +16.1% | +37.7% |
| IONS | SELL | 2019-03-19 | 2019-03-20 | $79.63 | $796K | +2.2% | -8.7% | -18.4% |
| IONS | SELL | 2018-05-11 | 2018-05-11 | $45.32 | $1.3M | -4.2% | -0.3% | +4.8% |
| ISIS | SELL | 2015-03-18 | 2015-03-20 | $71.41 | $893K | N/A | N/A | N/A |
| ISIS | SELL | 2015-03-05 | 2015-03-09 | $71.61 | $895K | N/A | N/A | N/A |
| ISIS | SELL | 2015-03-02 | 2015-03-04 | $65.97 | $462K | N/A | N/A | N/A |
| ISIS | SELL | 2015-02-12 | 2015-02-17 | $62.15 | $622K | N/A | N/A | N/A |
| ISIS | SELL | 2014-02-03 | 2014-02-05 | $48.78 | $229K | N/A | N/A | N/A |
| ISIS | SELL | 2014-01-22 | 2014-01-24 | $50.98 | $510K | N/A | N/A | N/A |
| ISIS | SELL | 2013-12-19 | 2013-12-20 | $39.58 | $781K | N/A | N/A | N/A |
| ISIS | SELL | 2013-11-26 | 2013-11-27 | $36.63 | $366K | N/A | N/A | N/A |
| ISIS | SELL | 2013-06-20 | 2013-06-24 | $20.93 | $114K | N/A | N/A | N/A |
| ISIS | SELL | 2008-07-03 | 2008-07-03 | $13.94 | $56K | N/A | N/A | N/A |
| RAMR | SELL | 2007-06-19 | 2007-07-20 | $15.50 | $34.1M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.